- Home
- APLS vs GENI Comparison
APLS vs GENI Comparison
Compare APLS & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- GENI
- Stock Information
- Founded
- APLS 2009
- GENI 2016
- Country
- APLS United States
- GENI United Kingdom
- Employees
- APLS N/A
- GENI N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- GENI Services-Misc. Amusement & Recreation
- Sector
- APLS Health Care
- GENI Consumer Discretionary
- Exchange
- APLS Nasdaq
- GENI Nasdaq
- Market Cap
- APLS 2.2B
- GENI 2.4B
- IPO Year
- APLS 2017
- GENI N/A
- Fundamental
- Price
- APLS $16.93
- GENI $9.57
- Analyst Decision
- APLS Buy
- GENI Strong Buy
- Analyst Count
- APLS 19
- GENI 13
- Target Price
- APLS $37.50
- GENI $11.81
- AVG Volume (30 Days)
- APLS 2.9M
- GENI 5.3M
- Earning Date
- APLS 05-07-2025
- GENI 05-06-2025
- Dividend Yield
- APLS N/A
- GENI N/A
- EPS Growth
- APLS N/A
- GENI N/A
- EPS
- APLS N/A
- GENI N/A
- Revenue
- APLS $775,839,000.00
- GENI $535,167,000.00
- Revenue This Year
- APLS $1.54
- GENI $23.39
- Revenue Next Year
- APLS $22.80
- GENI $16.36
- P/E Ratio
- APLS N/A
- GENI N/A
- Revenue Growth
- APLS 48.04
- GENI 22.89
- 52 Week Low
- APLS $16.10
- GENI $5.03
- 52 Week High
- APLS $43.76
- GENI $11.40
- Technical
- Relative Strength Index (RSI)
- APLS 41.44
- GENI 38.51
- Support Level
- APLS $16.61
- GENI $9.67
- Resistance Level
- APLS $17.48
- GENI $10.15
- Average True Range (ATR)
- APLS 0.86
- GENI 0.41
- MACD
- APLS 0.09
- GENI -0.07
- Stochastic Oscillator
- APLS 28.47
- GENI 6.15
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.